CAR T-Cell Therapy Market Set to Reach USD 13.56 Billion by 2031: Innovation Reshaping Cancer Treatment
Cancer remains one of the world’s leading health challenges, driving continuous innovation in oncology treatments. Among the most transformative breakthroughs in recent years is Chimeric Antigen Receptor (CAR) T-cell therapy, an advanced form of immunotherapy that harnesses the body’s own immune system to fight cancer. Unlike conventional treatments, CAR T-cell therapy genetically engineers...